Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top California based CEO’ operating in the Medical space. If you think a CEO’ is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Varsha Rao
Chief Executive Officer of Nurx
Varsha Rao is the CEO of Nurx, which is revolutionizing healthcare by home-delivering prescriptions, medication, and screening tests. She is a Board Member at ViaSat Inc., and the former COO of Clover Health, a health insurance startup developing an innovative platform that collects and analyzes long-term medical data to improve the health management and wellbeing of its clients. Varsha previously served as Head of Global Operations at Airbnb, where she was responsible for managing 16 offices across the globe and leading the company’s customer service and trust and safety teams in Oregon, Portland, Singapore, Dublin and San Francisco. Under her leadership, the company’s operations in Asia expanded, with many new hosts and visitors joining the Airbnb family. However, her entrepreneurial journey began much earlier, in 1998 when she founded Eve.com together with Mariam Naficy. Eve.com quickly became the leading e-commerce retailer for beauty and accessories. Within two years the company grew to 125 employees. Eve.com was sold to Idealab in early 2000 for $110M. In 1999, Fortune Magazine named the company as the 6th Best e-commerce site. Between founding Eve.com and landing at Airbnb, Rao has held a variety of senior roles. She was appointed VP, Category Marketing at Keen/Ingenio (acquired by AT&T) in 2001 and managed P&L for new and emerging major categories. In 2004-2008, she was VP, General Manager for OldNavy.com, the online division of Gap, Inc., where she led the company’s product development, marketing and merchandising efforts, resulting in a 60% increase in revenues. Rao went on to join SingTel as CEO, Digital Media in 2008 and led the team to launch its local search & reviews business inSing.com. After 3 years at SingTel she left to become Senior Vice President, International for LivingSocial where she was the first LivingSocial employee in Asia. As Senior VP, Rao managed more than 2,000 employees in the company’s network of offices in Asia, Australia, New Zealand, Latin America and Europe. Varsha is a Sequoia Capital Scout, and a mentor for the KStart Catalyst, an incubator and seed investment program for early stage startups in India. She herself has also invested in several startups in various fields including e-commerce, finance and renewable energy. In 2014, she was named by San Francisco Business Times as one of the ‘Most Influential Business Women’ in the Bay Area and in 2016 she featured in The Boardlist’s top 20 list of women every Silicon Valley tech company should be adding to their board. Rao received her BS/BA in Economics/Math from the University of Pennsylvania. For two years following graduation, she worked at the Wasserstein Perella financial consulting firm, where she advised clients on private and public investment strategies. She then returned to school to obtain an MBA from Harvard Business School. As a strong believer in the power of education she contributes to a variety of educational initiatives for underprivileged children and youth. Among them Breakthrough, a program that works to motivate and empower K12 students to continue to higher education and excel academically and professionally.
Follow Varsha Rao:
About Nurx: Nurx is a digital healthcare company offering 10 services across reproductive health, at-home testing, dermatology, migraine care, and more.
_______
Lin Jixun
Founder & CEO of ACON Laboratories
Lin Jixun has served as our director since 2008 and is the founder and chief executive officer of ACON Laboratories Inc., a worldwide leading manufacturer of high-quality rapid diagnostic test products. Mr. Lin founded ACON Laboratories Inc. in 1995 and serves on the company’s board of directors. He also serves on the board of directors for ACEA BioSciences Inc., a company providing innovative cell-based assay systems for basic life science research and drug discovery. Mr. Lin received his Ph.D. in microbiology and immunology from the Medical University of South Carolina and a Bachelor of Medicine from Zhejiang Medical University.
Follow Lin Jixun:
About ACON Laboratories: ACON Laboratories is a biotechnology firm that offers medical diagnostic and healthcare products.
Yi Liu
Founder & CEO of iHealth Labs
Follow Yi Liu:
About iHealth Labs: iHealth offers cloud-based, personal healthcare products for individuals of all ages to take a more active role in managing their health.
David Ko
Co-founder and CEO of Ripple Health Group
David Ko is the Co-founder and CEO of Ripple Health Group (RHG), an early stage healthtech startup focused on helping people experience healthier lives by connecting them to the care, support, and community they need. Prior to RHG, David was the President, COO and Board Member of Rally Health, a digital health company that develops online and mobile solutions that make it easy for consumers to take charge of their health and health care. Rally’s solutions are currently available to nearly 55 million people through health plans, care providers, and more than 200,000 employers. Prior to joining Rally, David oversaw all strategy, planning and operations as COO at Zynga, which he helped take public in December 2011. At the time of its IPO, Zynga was the largest social gaming company in the world with over 100 million daily active users. Prior to his work at Zynga, he spent 10 years at Yahoo! in various senior executive roles, including SVP of Yahoo!’s audience, mobile, and local businesses. David serves on the board of overseers at his alma mater New York University Stern School of Business where in 2016 he established the NYU Stern Venture Fellows program for aspiring entrepreneurs. He also works as an advisor and investor to a number of companies in Silicon Valley including Calm, the number one app for Sleep, Meditation and Relaxation.
Follow David Ko:
About Audax Health Solutions, Calm, Ripple Health Group: Ripple Health Group is a platform for the world’s most trusted healthcare solutions.
Stephanie Tilenius
CEO, Founder of Vida Health
Stephanie is CEO & Founder of Vida Health.
Follow Stephanie Tilenius:
About Nextdoor, Vida Health: Vida Health is a virtual care platform that provides health coaching from experienced health care providers and medical institutions.
Raja Dhir
Co-Founder and Co-CEO of Seed Health
Raja Dhir is a life sciences entrepreneur and Co-Founder of Seed Health, a venture-backed microbiome company pioneering the application of bacteria for both human and planetary health. He leads Seed’s R&D, academic collaborations, technology development, clinical trial design, supply chain, and intellectual property strategy. Together with Dr. Jacques Ravel, he Co-Chairs Seed’s Scientific Advisory Board–an interdisciplinary group of scientists and doctors who lead research teams and teach at institutions including the teaching hospital of Harvard Medical School and the Trial Innovation Unit of Mass. General Hospital (MGH). Raja has designed clinical trials with leading academic institutions including the teaching hospital of Harvard Medical School and the Trial Innovation Unit of Mass. General Hospital (MGH). Raja has unique expertise translating scientific research for product development with a track record that includes patented inventions to stabilize sensitive compounds to improve alpha-diversity of the gut microbiome (derived from micro-algae) and most recently, the co-invention of microbial technologies to protect honeybee populations (Apis mellifera) from neonicotinoid pesticides and pathogen colonization. His work also includes biofermentation and scale-up for both facultative and strict anaerobic organisms. Raja has negotiated multiple joint-ventures, strategic partnerships, technology transfer and licensing agreements with publicly traded companies (NYSE, LSE) and academic institutions (Harvard Medical School, UCLA). To date, entities he has co-founded own the rights to 15+ patents and research emerging from $25MM+ of non-dilutive funding over 10+ years from the Bill and Melinda Gates Foundation and National Institute of Health (NIH). Raja serves on the Editorial Board for the scientific journal, Microbiome. He is a member of the Microbiome Think Tank at Mass. General Hospital (MGH) and sits on the Advisory Committee for the International Scientific Association of Probiotics and Prebiotics (ISAPP). Raja is also a Director and Co-Chair of the Scientific Advisory Board for Micropia, a $20MM microbial ecology / education platform and the world’s first museum dedicated to microbes.
Follow Raja Dhir:
About Seed Health: Seed Health is a microbial company that focuses on therapeutics, consumer health innovations, and environmental solutions.
Ara Katz
Co-Founder and Co-CEO of Seed Health
Ara Katz is the Co-Founder and Co-CEO of Seed Health, a microbial sciences company pioneering the application of bacteria to impact human and planetary health. She has worked at the intersection of technology, consumer, design, and media is now working to steward a new standard in probiotics and how science is communicated to change how we discern evidence from evangelism to make the most informed choices for our bodies, our health, and our world. Ara previously co-founded and served as CMO of mobile commerce marketplace, Spring (backed by LMVH, sold to ShopRunner), and was on the founding team of social commerce company, BeachMint (sold to Conde Nast), where she launched six direct-to-consumer, influencer subscription brands. She is an angel investor and advisor in companies such as mindbodygreen, Stadium Goods (recently sold to FarFetch), RXDefine, women’s healthcare startup, Mahmee, and new biomaterials company, C16. Ara has been a fellow at the MIT Media Lab’s Center for Future Storytelling and CCA’s Design MBA program, was named in Marie Claire’s “The New Guard: The 50 Most Influential Women in America”, listed on Business Insider’s “Silicon Alley Top 100” and “36 Rockstar Women in NYC Tech”, and Create + Cultivate’s 100 List for STEM.
Follow Ara Katz:
About Seed Health: Seed Health is a microbial company that focuses on therapeutics, consumer health innovations, and environmental solutions.
David Kopp
Chief Executive Officer of Healthline Media
David leads the Healthline Media team. His 25 year career spans publishing, digital advertising, consumer services, and clientside marketing for both big brands (Disney and Yahoo!) as well as more entrepreneurial ventures. David believes that people need better tools, education, and support in order to achieve good health, and he’s confident that Healthline’s purpose-driven team will make the world stronger and healthier. He also talks a lot about sugar: if you want to live a long, healthy life, minimize your sugar intake.
Follow David Kopp:
About Healthline Media: Healthline Media is the 2nd largest and fastest growing consumer health publisher in the world, reaching 85 million people a month.
Sam Santhosh
Founder Chairman & Global CEO of MedGenome
Sam Santhosh is the Founder and CEO of MedGenome. He has been an entrepreneur, with over 20 years of experience in the software industry. Currently, he is at the helm of affairs as CEO and promoter of MedGenome Labs Pvt Ltd. Sam sits on the board of a number of companies, both in the US and India. In this role he advises, guides and mentors companies to help them grow and realize their true potential. Prior to this Sam was the CEO and Managing Director of California Software Limited (Calsoft) from 1992 – Feb 2012. He founded Calsoft in 1992 and under Sam’s vision, Calsoft rapidly grew from a niche player in the Silicon Valley to a global player with over 1200 employees and presence in 8 countries. Sam took Calsoft Public and the company is listed the in Indian Stock Exchanges. Sam oversaw the growth of Calsoft in all key areas – Finance, Strategy, Customer Acquisition, and inorganic growth through eight acquisitions including companies in the U.S, UK, Japan, and India. He has been constantly retooling himself and has attended various training programs in different U.S universities including MIT. In 2010, he completed the Executive Education program at the Singularity University in Sunnyvale, California. Sam has an engineering degree and an MBA (majoring in Management Information Systems) from India’s premier institute, IIM Calcutta.
Follow Sam Santhosh:
About Agrigenome, MedGenome: MedGenome develops a genomics-based diagnostics and research solution for healthcare providers to understand the genetic basis of diseases.
Tom Nix
CEO of Ria Health
Follow Tom Nix:
About Ria Health: Ria Health’s evidence-based telehealth alcohol treatment program helps people drink less and live better.
Jiang Li
CEO of VivaLnk
Jiang has both passion and extensive experience in bringing innovative technology and products into the marketplace. He has held various senior management positions in both large high tech organizations and startup companies. Prior to joining VivaLnk, he was responsible for new product and technology development as the VP of engineering in Kovio and Thinfilm Electronics, leading printed electronics companies. Prior to that, he worked at AMD and the joint venture between AMD/Fujitsu, Spansion. As the VP of product engineering in Spansion, Jiang managed the major new product launches in Spansion. Jiang holds a Ph.D. degree from the University of Wisconsin-Madison, and a bachelor’s degree from Zhejiang University in China.
Follow Jiang Li:
About VivaLnk: VivaLnk is a provider of connected healthcare solutions for in-patient and remote patient monitoring.
Paul Johnson
CEO of Lemonaid Health
Paul is the co-founder and CEO of Lemonaid Health. He moved from the UK to the US in 2014. In the UK Paul’s entrepreneurial career started aged 17 where I was a runner up in a Daily Mail sponsored entrepreneur of the year competition and founded his first company ran from the garage of his family home. Later Paul founded and ran the UK’s largest online pet retailer and became Head of Online for the second largest drugstore chain. Paul continues to advise McKinsey & Company and others on e-commerce, innovation and business strategy. In the UK Paul was an advisor to the Government on Entrepreneurism and Enterprise.
Follow Paul Johnson:
About Lemonaid Health: Lemonaid Health is a telemedicine platform that uses technology to change the way people interact with health care.
David E. Weekly
CEO of Medcorder
David is a nerd who likes people. David runs the product org for the datacenter software team at Google and previously helped launch internet.org at Facebook, helping to connect the species to the Internet. Before that, he started and ran Ohana (a service to help parents share videos of their kids with extended family) and PBwiki (the first private hosted wiki company), still used by millions of people a month. He was the Founding Director of Hacker Dojo, one of the world’s largest hackerspaces, located in Mountain View, and was the Founding Partner of Mexican.VC, Silicon Valley’s first seed fund for Mexican Internet startups and the best performing Mexican tech fund in history. David has been programming since he was five and graduated from Stanford with a degree in Computer Science as a President Scholar. He has worked in such widely varying technology environments as Harvard Physics Labs, MIT Lincoln Labs, Stanford Graphics Labs, atWeb (acquired by Netscape), myplay (acquired by Bertelsmann), Legato (acquired by EMC), and There.com (where he worked with Eric Ries, the inventor of The Lean Startup methodology). David has served as an advisor to dozens of technology companies, including Plaxo (acquired by Comcast), Attassa (acquired by YouSendIt), and Like.com (acquired by Google).
Follow David E. Weekly:
About Medcorder: Medcorder is a mobile app that helps families to coordinate and communicate about patient care.
Francis deSouza
CEO of Illumina
Francis A. deSouza, 50, has been President and Chief Executive Officer of Illumina, Inc., a biotechnology company, since 2016 and served as President of Illumina from 2013 to 2016. Prior to joining Illumina, Mr. deSouza was President, Products and Services, of Symantec Corporation from 2011 to 2013, and Mr. deSouza served as Symantec’s Senior Vice President, Enterprise Security Group, from 2009 to 2011. Prior to that time he founded or worked in a variety of other technology businesses. He has served as a Director of Illumina since 2014 and was a director of Citrix Systems, Inc. from 2014 to 2016. He was elected a Director of the Company in December 2017, effective February 1, 2018.
Follow Francis deSouza:
About Illumina: Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Jay Flatley
President & CEO of Illumina
Jay was appointed President and CEO of Illumina in 1999 and oversaw the company’s expansion into the whole genome sequencing area with the acquisition of Solexa in 2006, and more recently into diagnostics and consumer sequencing. Under his leadership, Illumina has been named multiple times to the Deloitte & Touche Fast 50 and Fast 500 lists, as well as to the Forbes 25 Fastest-Growing Tech Companies (2007, 2009 and 2010), the Fortune 100 Fastest-Growing Companies (2010 and 2011) lists, and recognition by MIT Technology Review as the World’s Smartest Company in 2014. Previously, Jay served as President and Chief Executive Officer of Molecular Dynamics. As a co-founder and member of the board of directors for Molecular Dynamics he led the company to its initial public offering in 1993. He helped Molecular Dynamics develop and launch over 15 major instrumentation systems, including the first capillary-based DNA sequencer. Currently, he is an Advisory Board member for UC San Diego’s Moores Cancer Center, and a member of the Board of Directors at Coherent, Denali, and Illumina, Inc. Jay received a B.A. in economics from Claremont McKenna College and a B.S. and M.S. (summa cum laude) in industrial engineering from Stanford University.
Follow Jay Flatley:
About Illumina: Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Erik Holmlin
President, CEO of Bionano Genomics
Erik Holmlin has two decades of experience in the life science and health care industries. His expertise spans technology development and commercialization, global marketing, commercial operations, venture financing, mergers & acquisitions and intellectual property. Recently, he served as president and CEO of GenVault Corporation, a life science company bring innovative solutions to biosample management. He merged GenVault with IntegenX, Inc. in January of 2011. He also served as an entrepreneur in residence (EIR) at Domain Associates, LLC, a leading dedicated life science venture-capital firm. Prior to these roles, Erik was chief commercial officer at Exiqon A/S, where he was responsible for global sales, marketing, and clinical affairs for two businesses: Oncology Services in a CLIA lab and Consumables Business in Life Sciences Research. In 2001 Mr. Holmlin led the formation of GeneOhm Sciences, Inc., for which, over a span of 5 years, he was director of chemistry, senior technology director, vice president of technology and business development, and vice president of marketing.
Follow Erik Holmlin:
About Bionano Genomics: BioNano Genomics develops nanoscale imaging and analytic platforms designed to analyze DNA and other genome-related peptides and proteins.
Mingzhe Ma
Chairman and CEO of Ping An
Mingzhe Ma is the founder of the Company. Mingzhe Ma founded Ping An Insurance Company in March 1988, and is the current Chairman and CEO of the Company. Since the establishment of the Company, Mingzhe Ma has served as President, Director, Chairman and CEO of the Company, and has been in charge of operations and management of the Company. Before establishing the Company, Mingzhe Ma was Deputy Manager of China Merchants Shekou Industrial Zone Social Insurance Company. Mingzhe Ma has a doctor’s degree in money and banking from Zhongnan University of Economics and Law (previously Zhongnan University of Economics).
Follow Mingzhe Ma:
About Ping An, Ping An Healthcare Management: Ping An Insurance Company is a holding company deals with insurance, banking, and financial service.
Nicholas Chang
CEO & Founder of The Pill Club
Follow Nicholas Chang:
About The Pill Club: The Pill Club provides online birth control prescription and at-home delivery services.
Seth Sternberg
Co-Founder & CEO of Honor
Seth Sternberg is the Co-Founder and CEO of Honor, a non-medical home care company with a mission to enable our parents to remain in their homes as they age. Prior to Honor, Seth was the Co-Founder and CEO of Meebo, which brought instant messaging to the web and reached close to half the internet population in the United States. Meebo was acquired by Google, where Seth became a Product Director working on the Google Identity Platform, and then within GoogleX. Seth started his career with IBM’s Corporate Development group after graduating from Yale.
Follow Seth Sternberg:
About Honor, Meebo: Honor is a senior care network and technology platform that offers personalized care to improve the in-home care experience.
Roy Paxton Yih
Co-Founder and CEO of Biocare Medical
Roy Paxton Yih, BS, MA, co-founded Biocare Medical, LLC in 1997 and serves as its Chief Executive Officer and President. Roy Yih served as a Director of Sales & Marketing at Biocare Medical LLC. Roy Yih is primarily involved at sales, marketing and business development activities. He holds a BS Degree in Biochemistry from U.C. Davis and an MBA from the University of Santa Clara.
Follow Roy Paxton Yih:
About Biocare Medical: Biocare Medical is a provider of immunohistochemistry instrumentation.
Chris Mansi
CEO, Co-Founder of Viz
Dr Mansi is a former Neurosurgeon and the CEO of Viz.ai an Applied AI Healthcare company.They recently received FDA clearance for the first ever AI aided triage and notification platform, opening the door to AI in acute emergency healthcare. Chris is a clinician innovator, entrepreneur and optimist focused on increasing healthcare access, building and supporting great teams and improving provider experience. Viz.ai builds clinician facing products that enable and empower doctors, allowing them to provide the best care to patients, everytime, everywhere.
Follow Chris Mansi:
About Viz: Viz is a medical imaging company that helps optimize emergency treatment using deep learning technology.
Daniel Perez
Co-Founder, CEO of Hinge Health
With a long personal history of MSK injuries including several leg surgeries, Dan has long been passionate about improving outcomes for musculoskeletal disorders. Originally from Miami, Dan pursued a PhD in the medical sciences at the University of Oxford (currently paused), founding the Oxbridge Biotech Roundtable and OneStart, a large healthcare accelerator program. As CEO, Dan brings startup technology experience and healthcare expertise to Hinge Health.
Follow Daniel Perez:
About Hinge Health: Hinge Health is a patient-centered digital clinic for treating chronic musculoskeletal conditions.
Maury Blackman
President & CEO of Premise Data
Maury Blackman is CEO of Premise Data. Blackman is a tech executive with more than 25 years of experience leading high growth enterprise software companies. His industry experiences include government, construction, public safety, geospatial information, GPO’s, sharing economy services, and drone software. Blackman joined Premise in 2017; under his leadership the company has seen 661% revenue growth. In November 2020, Premise was named to Deloitte’s Technology Fast 500, a list of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America. Premise is the 35th fastest-growing company in the Silicon Valley region and is 182nd on the overall list. Before joining Premise, Blackman was CEO at Accela, a civic tech company aimed at moving citizen transactions from city hall to online and mobile services. He joined the company in 2000 as the VP of Sales and Marketing and then assumed the role of CEO in 2007. To support strategic initiatives and growth, he raised more than $300M in financing from family offices, private equity, and senior debt. The capital from these raises was deployed to build out an enterprise offering, expand internationally, and execute an M&A strategy that closed 10+ acquisitions in 24 months. Prior to joining Accela, Maury worked for Investools (NASDAQ:IEDU) where he served in several executive positions from 1993 to 2000. At Investools, he first joined as an Account Executive and was later appointed Vice President, Business Development charged with selling data and content to brokerage firms and internet service providers in the nascent dot-com era. In this capacity, he built a dynamic portfolio of accounts that included Charles Schwab, Fidelity, AOL, and Netcom Online Communications. For his accomplishments at Accela, Blackman was recognized by Government Technology as one of its Top 25 Doers, Dreamers, and Drivers in 2015. In 2016, Ernst and Young awarded him the prestigious Northern California’s Entrepreneur of the Year. Maury holds a B.A. in Political Science from the University of Houston and was a commissioned field artillery officer in the United States Army, serving on both active and reserve duty for 10 years. Maury maintains an active lifestyle and is an eleven-time Ironman finisher, including the 2008 and 2013 Ironman World Championship in Kailua-Kona.
Follow Maury Blackman:
About Premise Data: Premise is a data and analytics platform powered by a global network of on-the-ground contributors, data science, and machine learning.
Zhen Li
Founder, President & CEO of ADARx Pharmaceuticals
Dr. Li is a co-founder of ADARx and a successful executive with more than two decades of diverse experience in research and development in the pharmaceutical and biotech industries. Prior to ADARx, Dr. Li served as Senior VP at Arrowhead Pharmaceuticals where she led the discovery and non-clinical development of Arrowhead’s delivery platform and multiple product candidates that are now in clinical studies. Previously, Dr. Li was a director at Merck, leading a team dedicated to siRNA development. Dr. Li received her Ph.D. in Chemistry and Chemical Biology from Harvard University, and her B.S. from Peking University.
Follow Zhen Li:
About ADARx Pharmaceuticals: ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
Dwight Crow
Co-Founder and CEO of Whisper
Dwight Crow is a product manager at [Facebook](https://www.crunchbase.com/organization/facebook#/entity), an online social networking service. Previously, he served as the founder of Carsabi.com. He is also the Co-Founder and CEO at Whisper.ai. Crow holds a bachelor’s degree in chemical biology and computer science from the [University of California, Berkeley](https://www.crunchbase.com/organization/university-of-california-berkeley#/entity). He is based in San Francisco, California, United States.
Follow Dwight Crow:
About Meta, Whisper: Whisper develops AI-enabled, updateable hearing aids for people with hearing loss.
Mehdi Maghsoodnia
Founder and Chief Executive Officer of 1Health
Mr. Maghsoodnia is currently serving as CEO of 1Health.io and Vitagene. He is also on the board of SpineZone and MedCorder. He previously served as CEO of Rafter, BookRenter.com, SVP of products at CafePress, COO at Actiance and SVP at Intellisync. Mr. Maghsoodnia is a industry fellow at UC Berkeley where he teaches innovation and entrepreneurship. He studies EECS in UCB and Stanford with an emphasis in AI and Machine learning.
Follow Mehdi Maghsoodnia:
About 1Health: 1health’s Testing as a Service (TaaS) Solution empowers precision testing and end-to-end process management in one simple, scalable tool.
Kim D. Blickenstaff
President and Chief Executive Officer of Tandem Diabetes Care
Kim joined Tandem in August 2007, bringing more than 30 years of healthcare experience in finance, marketing management, sales and strategic planning. Prior to joining Tandem, he was Chairman, Chief Executive Officer and co-founder of Biosite Incorporated, a medical diagnostic company that was acquired by Inverness Medical Innovations for $1.8 billion in June 2007. Prior to founding Biosite, he held various finance, operations, research management, sales management, strategic planning and marketing positions with Hybritech Incorporated and Baxter Healthcare. Kim has been active in the medical device and diagnostics industry over the last 12 years, serving on the board of directors for innovative, young healthcare companies such as SenoRx and MediVation Incorporated. He holds a Masters of Business Administration from Loyola University Chicago’s Graduate School of Business.
Follow Kim D. Blickenstaff:
About Tandem Diabetes Care: Tandem Diabetes Care develops medical devices for the treatment of diabetes offering diabetic insulin pumps for adults and children.
Paul Molloy
President & CEO of ClearFlow
Paul has over twenty years experience of operations, executive management and Board work at public, private and VC funded medical device companies. Two IPO’s at previous companies, particularly as President & Managing Director orchestrating LMA’s successful 2005 SGX listing at a market capitalization of >$300m. LMA was recently acquired by Teleflex in a process that he brokered. Paul was a practicing CRNA until he joined Datascope Corp in NJ in 1989, obtaining his MBA from the University of Chicago’s Booth School of Business and rising through executive positions with leading medical device firms to CEO level in successive start ups, most recently completing the sale of VasoNova to Teleflex Inc. He has extensive global industry connections and has traveled, lived and worked in Asia, Europe and the USA, including substantial experience setting up and managing operations in Australia, Germany, Switzerland, Singapore, China, Japan, India and Latin America as well as serving on the Board of those local subsidiaries.
Follow Paul Molloy:
About ClearFlow: ClearFlow is a medical device company developing technologies to solve clinical problems associated with obstructed catheters.
Philip Fung
Founder / CEO of Kit.com
Founder/CEO @Kit.com, Engineer #15 @Facebook
Follow Philip Fung:
About Kit.com: Kit.com is a home medical exams, delivered. Kit makes health testing simpler, easier and more reliable for your patients.
Drew Perkins
Co-Founder and CEO of Mojo Vision
Follow Drew Perkins:
About Mojo Vision: Mojo Vision is developing Mojo Lens, the world’s first AR smart contact lens with a built-in display that delivers Invisible Computing
Fei Li
Chief Executive Officer & Chairwoman of Hycor Biomedical LLC
Fei Li first joined Hycor in 2016 as President and Chairwoman of the Board. In September 2017, she became President and CEO of Hycor. Dr. Li has over 20 years’ experience in the fields of in vitro diagnostics (IVD), medical devices and Clinical Medicine. Over her distinguished career, Dr. Li has consistently demonstrated her ability to deliver results as she has led teams that improved product design, realized operational efficiency and recognized investment opportunities in the domestic and international healthcare sector. Dr. Li’s strengths include her extensive experience in building and empowering a team to manage through organizational growth to improve processes, decrease costs and accelerate business performance. Dr. Li also has extensive investment experience in the healthcare industry. She has successfully executed cross-border transactions and has been effective in managing pre- and post-investment activities between stakeholders and investment targets. Dr. Li has had the distinction of serving in multiple strategic roles including Chief Operating Officer for QuantumTech Medical Devices during 2016-2017, Chief Operating Office for Beyond Diagnostics Inc. between 2008 – 2011, Head of Business Development for Siemens Healthcare China from 2007 – 2008 and Director of Product Validation for Diagnostic Products Corporation from 2006 – 2007. Dr. Li holds a medical degree from San Yat-Sen University in Guangdong, China. In addition, she received a Ph.D. degree in Biomedical Sciences from the University of California, Riverside and a Master of Business Administration (M.B.A.) from the University of Redlands.
Follow Fei Li:
About Hycor Biomedical LLC: Hycor Biomedical is a medical device company that provides vitro diagnostics products.
Cheng Liu
Founder, CEO of Eureka Therapeutics
Cheng Liu is the founder and CEO of Eureka Therapeutics, a California biotech company dedicated to antibody research and discovery for cancer immunotherapy. Prior to founding Eureka, Dr. Liu was a Principal Scientist in antibody drug discovery at Chiron (now Novartis), where he championed anti-CSF1 antibody program for treatment of bone metastasis to human clinical trials. He is the inventor of multiple issued US patents in drug discovery. In 2007, he was awarded Special US Congressional Recognition for his contributions to improving human health. Dr. Liu received his B.S. in Cell Biology and Genetics from Beijing University and a Ph.D. in Molecular Cell Biology from the University of California, Berkeley.
Follow Cheng Liu:
About Eureka Therapeutics: Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Maria Artunduaga
Founder and CEO of Respira Labs
Follow Maria Artunduaga:
About Respira Labs: Respira Labs is building an AI-powered sensor platform to track, predict, and prevent chronic lung disease.
Sami Inkinen
CEO & Founder of Virta Health
Sami Inkinen is the Chief Executive Officer and Co-Founder of Virta Health, a specialty medical clinic that reverses type 2 diabetes safely and sustainably, without the risks, costs, or side effects of medications or surgery. Previously, Mr. Inkinen was the co-founder of the leading online real estate marketplace Trulia, serving as its COO and president and board member until its IPO and eventual sale to Zillow Group. He also worked on Microsoft’s strategy team for MS Office, and as a consultant for McKinsey & Company within the software, telecommunications, and government sectors. A physicist by training, Mr. Inkinen started his career as a radiochemist at a nuclear power plant and holds a Master of Science in engineering physics from the Helsinki University of Technology. He also earned a Master of Business Administration from Stanford University. He thinks his greatest luxury today is a small vegetable garden at his San Francisco Bay area home.
Follow Sami Inkinen:
About Virta Health: Virta delivers a clinically-proven treatment to reverse type 2 diabetes and other chronic metabolic diseases.
Erica Chidi
Co-Founder & CEO of LOOM
Erica Chidi is a Co-Founder and Chief Executive Officer at LOOM.
Follow Erica Chidi:
About LOOM: LOOM is a platform helping women optimize their sexual and reproductive wellbeing.
Stephen Chen
Founder & CEO of Scanwell Health
Co-Founder and President at Learn To Be Foundation. Founder at Petnostics.
Follow Stephen Chen:
About Learn To Be Foundation, Petnostics, Scanwell Health: Scanwell Health is an FDA-cleared urine testing application.
Fabien Beckers
Founder & CEO of Arterys
Fabien Beckers is the CEO and co-founder of Arterys, a cloud/deep learning startup that is disrupting the medical imaging space and building image-based precision medicine tools. Fabien has led the growth of the company from four co-founders to a team of 34 today. Under his leadership, the company has become a pioneer in cloud-based medical imaging software, offering the first FDA-cleared end-to-end cloud infrastructure for medical imaging. They key advantages of the platform being automatic aggregation of real-world data and ability to scale and distribute the processing of increasingly large, complex datasets. Fabien’s vision for the company is to accelerate data-driven medicine by building precision medicine tools based on the consistent quantification of medical image features in combination with molecular, genomics and patient history data. Fabien holds a PhD in Quantum Physics from the University of Cambridge and a masters of business from Stanford University.
Follow Fabien Beckers:
About Arterys: Arterys is a medical imaging platform to deliver clinical AI products over the internet.
Amit Vohra
Co-Founder, President & CEO of Promaxo
Promaxo is led by Dr. Amit Vohra who is a serial entrepreneur, business strategist and advisor to several healthcare and technology startups. Amit is a Partner in Advanced Biopharma Consulting, a management consultancy offering strategic business development and commercialization services in the life sciences space. He also serves as an advisor to Cricking, MedDx and HealthyX and a strategy consultant to Precision Biopsy and Weinberg Medical Physics. Prior to Promaxo, Amit was the CEO/President of Convergent Life Sciences wherein he took a MRI-US fusion product, for targeted laser ablation of soft tissue cancer, through FDA clearance within 18 months of Company formation. Previously, as VP of Strategy and Operations at Eigen, he led the development and successful commercialization of two class II medical devices in the prostate biopsy space. In 2009, Amit co-founded Navya Biomedical Technologies, a biotechnology company using proprietary polyhydroxy fullerenes (PHF) for non-invasive imaging and destruction of solid tumors. Amit has a Doctorate in Mechanical Engineering from University of Florida, and an Executive MBA (Fuqua Scholar) from Duke University’s Fuqua School of Business.
Follow Amit Vohra:
About 8chili, Neuro42, Promaxo, TriOcula Technologies: Promaxo is commercializing customer-centric MRI systems and robotic guidance tools for live diagnosis and treatment in a physician’s office.
Paul Grand
CEO of MedTech Innovator
Follow Paul Grand:
About MedTech Innovator: MedTech Innovator is the largest lifescience accelerator in the world for medical device, digital health, and diagnostic companies
Deborah Kilpatrick
Chief Executive Officer of Evidation Health
Deborah Kilpatrick is the Chief Executive Officer of Evidation Health.Prior to this role, she served as the Chief Commercial Officer of genomic diagnostics company CardioDx. Earlier in her career, Deborah held multiple leadership roles at Guidant Corporation, including Research Fellow, Director of R&D, and Director of New Ventures in the Vascular Intervention Division. She serves on the Georgia Tech Advisory Board and is a Fellow of the American Institute of Medical and Biological Engineering. Deborah is a co-founder of the MedtechVision Conference, now held annually in Silicon Valley. She holds BS, MS and PhD degrees in mechanical engineering with a bioengineering focus from Georgia Tech.
Follow Deborah Kilpatrick:
About Evidation Health, MedTech Women: We enable and empower everyone to participate in better health outcomes.
Walter De Brouwer
Co-Founder & CEO of doc.ai
CSO & founder at doc.ai, Chief Executive Officer at XY.ai, Chair at IEEE, Stanford MD Admissions MMI Rater at Stanford University & Investment Banker at Lazard Asset Management.
Follow Walter De Brouwer:
About doc.ai, Lazard Asset Management, Stanford University, Stanford University School of Medicine, XY.ai Inc., Yale School of Management (SOM): doc.ai is a digital health company designed for a new generation of medical research.
Uday Kumar
Founder, President, CEO, and Board Member of Element Science
Co-Founder & Board Member at Sympara Medical – Dr. Uday N. Kumar, a cardiologist and cardiac electrophysiologist by training.
Follow Uday Kumar:
About Element Science, Stanford University, Sympara Medical: Element Science is a medical device and digital health start-up that develops lifesaving wearable solutions.
Hira Thapliyal
Founder, President & CEO of Aneumed
Hira Thapliyal is the founder, president & CEO of AneuMed, Inc.AneuMed is an early stage company engaged in developing devices for the treatment of various ailments affecting the human cardiovascular system. Prior to that, Dr. Thapliyal was the co-founder, president & CEO of VytronUS, Inc., a development stage company working on products for treatment of cardiac arrhythmias. Currently, VytronUS is conducting human clinical trials for its products. Before that, Hira was the co-founder, president & CEO of Tescient, Inc. Tescient was focused in developing products aimed at tissue regeneration and wound healing in human body. Tescient prototype products did not perform well in early animal tests, so Dr. Thapliyal closed Tescient and returned 60% of the invested capital back to the investors. Prior to Tescient, Dr. Thapliyal co-founded ArthroCare Corp (NASDAQ: “ARTC”) in 1993, and served its president & CEO and took the company public in 1996. ArthroCare was recently acquired by Smith & Nephew for $1.7 billion. ArthroCare markets products in the field of arthroscopy, ENT, spine, skin, and wound healing. Before ArthroCare, Hira served as the president of MicroBionics, a company developing products for continuous measurements of blood parameters in critically ill patients. Before MicroBionics, Hira co-founded and served as the president of CardioVascular Imaging Systems (NASDAQ: “CVIS”) which developed and marketed an ultrasound based imaging system, Intravascular Ultrasound (‘IVUS’), for the human blood vessels. CVIS went public and was later acquired by Boston Scientific (“BSX”). Prior to that, Hira served as the Vice President of Devices for Vascular Interventions (DVI) which developed and marketed products for removal of plaque form inside on the diseased arteries. DVI was acquired by Eli Lilly in 1989. Prior to DVI, Dr. Thapliyal held engineering and management positions at Oximetrix, Inc., Amdahl, and Corning. Dr. Thapliyal holds a BSEE degree from Washington State University, a MSEE from University of Idaho, and a PhD degree in Materials Science & Engineering from Cornell University. Hira has received numerous awards, and currently serves as an advisor to the Stanford-India Biodesign Program at Stanford University. Dr. Thapliyal also served as a judge for the Entrepreneur of the Year award at Earnst & Young. Dr. Thapliyal currently holds over 193 issued US and International patents for various medical devices.
Follow Hira Thapliyal:
About Aneumed, VytronUS: Aneumed is a biotechnology company based in California, United States.
Naama Stauber Breckler
CEO & Co-Founder of Better Health
Naama is a healthcare entrepreneur and the CEO and Co-founder of Better Health. She holds an MBA from Stanford GSB and is an experienced software engineer and product manager. She is dedicated to creating human centric healthcare solutions to improve our healthcare system. Naama previously co-founded CompactCath, MocaCare and Avails Medical.
Follow Naama Stauber Breckler:
About Avails Medical, Better Health, MOCACARE: Better Health offers an end-to-end care solution, bundling peer-support, coaching, education and home delivery of medical supplies
Lucia Huang
Co-Founder and CEO of Osmind
Lucia is CEO and co-founder of Osmind. We’re building a care platform for treatment-resistant mental health to accelerate drug development & precision medicine. She was previously Director of Operations & Finance and employee #10 at Verge Genomics (YC S15), an early stage AI-driven biotech startup focused on brain diseases. She began her career in healthcare in investment banking at Evercore and then as a investor at Warburg Pincus focused on growth-stage healthcare IT companies. She will complete her MBA at Stanford Graduate Business School of Business in June 2020 and studied Chemistry at Yale.
Follow Lucia Huang:
About Osmind: We build software and accelerate research for the future of mental health.
Adegoke Olubusi
Co-founder & CEO of Helium Health
Goke is one of Africa’s finest entrepreneurs at the forefront of technology disruptions across Africa. A Johns Hopkins University alumni and previously an engineer at eBay, PayPal and Goldman Sachs in the U.S., Goke has a penchant for solving tough problems. He served on the founding team of Africa’s leading social network with 30m+ users and received multiple honours/awards from Forbes, Chevron, Northrop Grumman, Lockheed Martin, etc.
Follow Adegoke Olubusi:
About Helium Health, MAGIC Fund: Helium Health is an EHR company specializing in developing hospital software to manage patients’ health records and data.
Andrew Lockhart
Co-Founder, Board Member & Chief Executive Officer of Fathom
Follow Andrew Lockhart:
About Fathom: Fathom develops a coding automation platform designed to expedite medical coding practice.
Kristina Cahojova
Founder & CEO of kegg
Kristina Cahojova is the Founder and CEO of Kegg.
Follow Kristina Cahojova:
About kegg: Kegg is a two-in-one device that combines fertility tracking with pelvic floor exercising.
Joseph DeVivo
CEO of InTouch Health
Joseph M. DeVivo, Chief Executive Officer of InTouch Health, brings a proven track record of 30 years of extensive business leadership and 25 years of medical device experience, ranging from small startups to large corporations. Prior to joining InTouch Health, Joseph served as President, Chief Executive Officer and Director at Angiodynamics (NASDAQ: ANGO) from September 2011 through the summer of 2016. Joseph also held positions as Global President of Smith & Nephew Orthopedics (NYSE: SNN) between 2007 to 2011, President and Chief Executive Officer and Director of RITA Medical Systems, Inc. from 2003 to 2007, President, Chief Operating Officer and Director of Computer Motion Incorporation (CMI) from 2002 to 2003, and Vice President, General Manager at U.S. Surgical/Davis (USS/DG), a division of Tyco International’s Healthcare Business, from 1993 through 2002. Joseph received his Bachelor’s degree in Business Administration from the E. Clairborne Robins School of Business at the University of Richmond in 1989. Active in industry leadership as well as philanthropy, Joe is a member of the board of Mauna Kea Technologies, (EPA:MKEA) and St. Jude’s Children’s Research Hospital raising over $1,000,000 for the benefit of the Hospital.
Follow Joseph DeVivo:
About AngioDynamics, AngioDynamics, Computer Motion, Inc, InTouch Health, RITA Medical Systems, Inc, SurgiQuest: InTouch Health is the leader in Acute Care Telemedicine solutions.
Surendar Magar
President and CEO of LifeSignals
Surendar Magar has over 30 years’ experience in the technology industry. He co-invented the Texas Instruments TMS320, the groundbreaking digital signal processing architecture that launched the DSP industry. Later he co-founded Athena Semiconductors, an early developer of the wireless networking platform that would become Wi-Fi; Athena was acquired by Broadcom Corporation.
Follow Surendar Magar:
About LifeSignals: LifeSignals’ offers innovation in wearable biosensor technologies to address a broad set of needs and opportunities throughout healthcare.
Aleksandar Cabrilo
CEO of HTEC Group
Aleksandar is an entrepreneur by passion. He is the founder and CEO of HTEC Group, a consulting and technology R&D services company, founded in Serbia and grown internationally, headquartered in San Francisco with offices in Serbia, Scandinavia, and the UK, servicing its clients and partners globally in various verticals. Aleksandar has a special interest in business digitalization, corporate innovation, and venture acceleration and in HTEC he makes sure that technology excellence of its engineering teams meets relevant industry domain expertise to create the disrupting digital products that support innovative business models. Aleksandar is also a partner, advisor or investor with several technology startups.
Follow Aleksandar Cabrilo:
About HTEC Group: HTEC Group is a consulting, product development and digital platform engineering company.
Alex Meshkin
Co-Founder & CEO of Flow Health
Alex Meshkin is currently Co-Founder and Chief Executive Officer of GroupMD, a patient care social network enabling healthcare providers to effectively communicate, collaborate and coordinate care. Additionally, Meshkin is Executive Chairman of huvi, a social commerce platform, enabling consumers to buy and sell digital movies. huvi works in partnership with major Hollywood studios to reduce piracy, monetize consumer to consumer transactions and enable a secondary market for digital goods. In 1999, at the age of 19, Meshkin launched his first consumer internet start-up and experienced the ups and downs of entrepreneurship. In the years that followed, Meshkin became the CEO of Toyota Motorsports’ flagship NASCAR racing team, Bang! Racing. Toyota selected the young Meshkin from 83 NASCAR race team candidates; to lead Toyota’s factory supported NASCAR racing team. Toyota’s partnership with Meshkin created one of the most successful racing organizations in its first year of operations. In 2004, Bang! Racing made NASCAR history – setting numerous milestones. As the principal owner of Bang! Racing, Meshkin became the youngest team owner in NASCAR history and the team became the most successful first year NASCAR race team – winning Toyota’s first two races in their inaugural season. Bang Holdings, the parent company of Bang! Racing was also a success off the race track. In its first year of operations, Bang generated over $15 million in revenues; partnered with Vertrue to form a joint venture; and with their strategic technology partner eBay created and operated a NASCAR consumer membership and affinity marketing club. By the age of 23, Meshkin was one of NASCAR’s elite team owners and a recurring guest on Fox News Channel and CNBC Squawk Box; and featured in numerous publications, including Fortune, Sporting News, Racer, Associated Press and Sports Illustrated. Bang! Racing sponsors included, Toyota Motor Sales, DuPont, Viacom (Showtime Networks), Line-X, Valvoline and Snap-On Tools. In 2005, the race team was acquired by Toyota Motorsports and Bill Davis Racing. The technology divisions were merged in 2006 into Cloverleaf Partners and the NASCAR membership club became FastTrack Savings operating as DealPass.com. Prior to Bang! Racing, Meshkin founded and operated a global software development company and interactive agency with a focus on healthcare and pharmaceuticals with clients such as Johnson & Johnson and Eli Lilly. Additionally, Meshkin served as Director of Product and Strategic Development of cyberCFO, a venture funded financial services firm and later as VP and GM at Cloverleaf Partners. Keep up with Alex on Twitter @alexmeshkin. And to learn more about please visit his blog at http://alexmeshkin.com and LinkedIn: http://linkedin.com/in/meshkin. Check out his videos on YouTube: http://www.youtube.com/alexmeshkin
Follow Alex Meshkin:
About Flow Health, GroupMD: Flow Health is a collaboration platform based of universal health data, combining data from all sources around a patient
William Facteau
CEO of Earlens
Follow William Facteau:
About Earlens: Earlens is a privately held medical technology company transforming the hearing experience with the only direct sound delivery system.
Steven Eidelman
Co-Founder and CEO of Modern Animal
Steven Eidelman is the Co-Founder and CEO of Modern Animal. He co-founded Whistle following his time at Spectrum Equity, where he focused on investments in consumer Internet. Previously he spent time driving online strategy for Warner Music Group and working at Bain for a number of technology, healthcare, and private equity clients. Steven graduated from the University of Pennsylvania with a BA in Political Science.
Follow Steven Eidelman:
About Modern Animal: Modern Animal is an innovative veterinary platform building a new kind of veterinary experience for animals and humans.
Farhad Khosravi
Chairman & CEO of Imperative Care
Farhad Khosravi is the Executive Chairman and Co-Founder at Tulavi Therapeutics.
Follow Farhad Khosravi:
About Access Closure, Embolic Protection, Hotspur Technologies, Imperative Care, Imperative Care, Incept, Instylla, Ocular Therapeutix, Ostial Corporation, Tulavi Therapeutics, Tulavi Therapeutics: Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Serge Saxonov
Co-founder & CEO of 10X Genomics
Serge Saxonov is the founder and chief executive officer of 10X Genomics. Prior to that, he was the vice president for applications at QuantaLife. Saxonov holds a PhD in biomedical informatics from Stanford University. He has also studied applied mathematics at Harvard University. Saxonov lives in San Francisco, California, United States.
Follow Serge Saxonov:
About 10X Genomics: 10X Genomics ELV solutions and security systems company that provides an innovative genomics platform.
Noga Leviner
Co-Founder & CEO of PicnicHealth
Noga was inspired to create Picnic after being diagnosed with an autoimmune disease and struggling to keep track of her own health data. She had previously co-founded Lumni USA, where she raised and deployed the first US investment fund to help underserved students access low-risk, equity-style student loan products. She has been a regular speaker and consultant on financial innovation for the underbanked and, more recently, an advocate for patient data access in the healthcare system. Noga has a BA from Stanford where she studied Human Biology and Economics. She can regularly be found spacing out while trying to meditate.
Follow Noga Leviner:
About PicnicHealth: PicnicHealth helps patients easily access their medical records and gives them the opportunity to contribute data to medical research.
Akilesh Bapu
Co-Founder and CEO of DeepScribe
Follow Akilesh Bapu:
About DeepScribe: DeepScribe is an AI-driven platform for medical record-taking.
Rakesh Mathur
Co-Founder & CEO of Whiterabbit.ai
Rakesh is a co-founder of Webaroo. He has been a founder of three technology start up companies in the past 10 years and also an early stage investor in several other companies. He was a founder and CEO of Junglee, whose virtual database technology led to the creation of comparison shopping on the Internet. Junglee was acquired by Amazon.com in 1998. He founded Armedia, which was one of the first companies with chip designs for the video component of the DVD standard. Armedia was acquired by Broadcom in 1999. He also founded PurpleYogi, now Stratify which provides enterprise solutions to the management of unstructured data. Rakesh is a board member of Geodesic, a BSE listed company whose Mundu Instant Messenger is used by millions of people. Rakesh was recognized as a member of the 1998 Upside 100, the 2001 India Today Global 100 and Junglee technology was given the Computerworld – Smithsonian award as one of the top five technologies of 1998. Rakesh received his MS from the University of Texas at Arlington and his B.Tech from IIT Bombay.
Follow Rakesh Mathur:
About GupShup, Percipient.ai, Terralogic, WhiteRabbit, Whiterabbit.ai: Whiterabbit.ai develops software using artificial intelligence to detect cancer at the earliest stages.
Kyle Robertson
Founder and CEO of Cerebral
Kyle Robertson is the Co-Founder and Chief Executive Officer of Cerebral.
Follow Kyle Robertson:
About Cerebral: Cerebral is a mental health telemedicine company that offers online care and medication management for anxiety, depression, ADHD and more.
Christian Gormsen
CEO of Eargo
Growing up across the world, Christian dreamed about a career in the NBA, but alas that was not to be. So, he decided on a wildly successful career in the hearing health and professional services industry instead. Over two decades, Christian has been instrumental in growing the hearing health and professional services market for leading global companies. We lured him from Copenhagen with the promise of a try-out with the Golden State Warriors.
Follow Christian Gormsen:
About Eargo: Eargo makes direct-to-consumer hearing aids, allowing customers to access help for their hearing loss from their homes.
Ben Lewis
CEO of Limbix
Ben Lewis is the co-founder of Tapjoy. He has an undergraduate degree in engineering from the University of Michigan, and his first job out of college was working as an engineer on Xbox Live. After spending some time at Microsoft, he returned to Michigan for his MBA where he focused on entrepreneurship and technology. Ben then moved to Google where he spent 4 years as a Product Manager, working on products such as the Toolbar, Search, and Checkout. Ben left Google to found Tapjoy, which began with the launch of TapDefense. Ben now leads the Tapjoy product team and manages accounts for the top publishers.
Follow Ben Lewis:
About Green Shoots Distribution, Limbix: Limbix is a prescription digital therapeutics platform that provides mental health treatment for young people.
Konstantinos Alataris
Founder, CEO of Nesos
Konstantinos Alataris is the President and CEO of the Nevro Corp. Prior to founding Nevro, Dr. Alataris was a venture capitalist with Bay City Capital in San Francisco, focusing on investment and strategic advisory services. He was previously a Business Development Manager with Compass, Guidant’s Corporate Venturing Group, where he analyzed and structured medical device/healthcare investments and evaluated acquisition targets. He was also a Research Fellow at the House Ear Institute, a research center and clinic in Los Angeles. Dr. Alataris holds a Ph.D. in Biomedical Engineering, an MBA, and an M.S. in Electrical Engineering from the University of Southern California. He received a BS in Electrical Engineering and Computer Science from the National Technical University of Athens, Greece.
Follow Konstantinos Alataris:
About Nesos: Nesos develops wearable interfaces and software components for the treatment of neurological disorders.
Joseph Huang
CEO of StartX (Stanford-StartX Fund)
Follow Joseph Huang:
About StartX (Stanford-StartX Fund): StartX is an educational non-profit that helps Stanford’s top entrepreneurs.
Talha Sattar
CEO & Founder of NimbleRx
Follow Talha Sattar:
About NimbleRx: Nimble provides a pharmacy experience centered around the patient’s needs to provide a more streamlined workflow.
David Kim, MD
CEO of DigiTx Partners
David is the CEO of DigiTx Partners, bringing both business and clinical expertise to venture capital with an extensive background practicing medicine and building healthcare software companies. Most recently, Dr. Kim served as the COO of Lumiata, a venture-backed predictive analytics company positioned at the intersection of data science and medical science. Prior to Lumiata, he spent over a decade as an investor evaluating and growing healthcare companies at MPM Capital and Pinnacle Ventures. Before entering the business sector, David practiced as a general internist and hospitalist at Kaiser South San Francisco where he also served as the Director of Urgent Care and Assistant Chief of Internal Medicine. David completed his internal medicine residency at Harbor-UCLA Medical Center and is a graduate from the Johns Hopkins University School of Medicine (M.D), Stanford Graduate School of Business (M.B.A.), and Pomona College (B.A., Biology). In addition to leading the DigiTx fund, David serves as an active advisor to the Catalyst Program within the UCSF Clinical & Translational Science Institute.
Follow David Kim, MD:
About DigiTx Partners: DigiTx Partners is an early-stage venture capital firm investing in digital health.
Martyn Gross
Co-Founder & CEO of Zerigo Health
Advisor at Cooler Heads Care & Chief Business Officer at Mindera.
Follow Martyn Gross:
About Dthera Sciences, MiNDERA Corporation, Zerigo Health: Clarify Medical is a developer of a handheld medical device used to treat psoriasis, eczema, and vitiligo .
Kyle Michelson
Founder & CEO of Getlabs
Kyle Michelson is the Founder and CEO of Getlabs. He is a former Founder of Streamup and Instameet.
Follow Kyle Michelson:
About Getlabs: Getlabs delivers healthcare to patients with in-person medical professionals.
Nitin Nanda
CEO,Founder & Chairman of Aligned TeleHealth
Dr. Nitin Nanda, founder of Aligned Telehealth, is a respected physician, entrepreneur, leader, and educator. Since founding the Company in 2000, Dr. Nanda has grown Aligned Telehealth into one of the largest behavioral health specialty practices in the US. He built a successful practice model based on clinical expertise, compassion, operational efficiency and fiscal responsibility. He is Assistant Clinical Professor at the UCLA David Geffen School of Medicine and Clinical Assistant Professor in Medicine at the USC Keck School of Medicine. Dr. Nanda is Chief of Psychiatry and Behavioral Health at the Los Angeles Jewish Home. He also serves as Medical Director of the Lisa and Ernest Auerbach Geriatric Psychiatry Unit at the Joyce Eisenberg-Keefer Medical Center in Los Angeles. Dr. Nanda obtained his medical training in India and served briefly in Africa, where he worked with community hospital and clinics, caring for the very ill and underserved. He then joined UCSF School of Medicine’s Clinical Research department. Later, Dr. Nanda completed an Internship and Residency at the UCLA David Geffen School of Medicine, where he was nominated Chief Resident. With a deep interest and passion in caring for seniors, Dr. Nanda pursued a Geriatric Psychiatry Fellowship at UCLA.
Follow Nitin Nanda:
About Aligned TeleHealth, Amwell: Aligned Telehealth is a provider of a SaaS-based platform used to offer telemedicine and healthcare management services.
Terren Peizer
Founder & CEO of Ontrak
Mr. Peizer is an entrepreneur, investor, and financier with a particular interest in healthcare, having founded and successfully commercialized several healthcare companies. Mr. Peizer is the founder of Catasys, Inc., a leader in behavioral and mental health management services. He has also served as the Company’s Chairman of the Board of Directors and CEO since the Company’s inception in 2004. Mr. Peizer also is the Founder, Chairman and CEO of NeurMedix, Inc., a biotechnology company with a focus on inflammatory, neurological and neuro-degenerative diseases. NeurMedix’s lead compound NE3107 has shown efficacy in 11 pre-clinical and 6 human studies. These studies resulted in publications in peer-reviewed journals. Mr. Peizer is Chairman of Acuitas Group Holdings, LLC, his personal holding company that is the owner of all of his portfolio company interests, including Catasys, Inc. Through Acuitas, Mr. Peizer also owns Crede Capital Group, LLC, an industry leader in investing in micro and small capitalization equities, having invested over $1.2 billion directly into portfolio companies. Mr. Peizer has been the largest beneficial shareholder, and has held various senior executive positions with several other publicly-traded growth companies, including Chairman of internationally renowned Cray, Inc., the industry’s leading supercomputer company. Mr. Peizer has a background in venture capital, investing, mergers and acquisitions, corporate finance, and previously held senior executive positions with the investment banking firms Goldman Sachs, First Boston, and Drexel Burnham Lambert. He received his B.S.E. in finance from The Wharton School of Finance and Commerce. Raised in Beachwood, Ohio, a suburb of Cleveland, Peizer has been the largest beneficial stockholder and has held various senior executive positions within several technology and biotech companies. He has assisted companies by assembling management teams, boards of directors and scientific advisory boards, formulating business and financial strategies, and investor relations. Mr. Peizer has a background in venture capital, investing, mergers and acquisitions, corporate finance, and previously held senior executive positions with the investment banking firms Goldman Sachs , First Boston and Drexel Burnham Lambert . Mr. Peizer received his B.S.E. in Finance from The Wharton School of Finance and Commerce. Over the years, Terren Peizer has frequently noted the importance of his family and his Ohio upbringing in various interviews. He has stated that his half brother’s problems with addiction spurred him to found Hythiam, and has named his investment companies after his hometown and home street. Although he has been called “One of Wall Streets top players” Peizer has also exhibited a humble and modest lifestyle consistent with his Midwestern upbringing. It is believed that he still lives in the same condominium home he first purchased in the 1980s when he moved to Los Angeles, California You can follow more of Terren at his personal site: http://www.terrenpeizer.com
Follow Terren Peizer:
About BioVie, Ontrak: Ontrak provides health management services for health plans, employers and unions through a network of licensed healthcare providers.
Fabian Gerlinghaus
Co-Founder & CEO of Cellares
Fabian Gerlinghaus is the CEO and Co-Founder of Cellares.
Follow Fabian Gerlinghaus:
About Cellares: Cellares is a life sciences technology company that develops the Cell Shuttle to automate cell therapy manufacturing.
Russell Cook
Chief Executive Officer of Ventris Medical
Follow Russell Cook:
About Ventris Medical: Ventris Medical design, develop and market a wide range of allograft, bioactive and synthetic products for all types of tissue application.
Connor Landgraf
Co-Founder & CEO of Eko Health
Connor Landgraf is the co-founder and CEO of Eko.
Follow Connor Landgraf:
About Eko Health: Eko develops AI-powered digital tools to detect and monitor heart and lung disease
Maayan Cohen
CEO & Co-Founder of Hello Heart
Co-Founder, CEO at Hello Doctor
Follow Maayan Cohen:
About Hello Heart: Hello Heart is the leader in cardiovascular digital therapeutics. We help people understand and improve their heart health using technology.
Wenbin Jiang
Co-Founder and CEO of Cytek Biosciences
Wenbin Jiang is a co-founder of Cytek Biosciences, Inc. and a seasoned entrepreneur and inventor. E2O communications was the first company he cofounded in late 1990s, which was acquired by JDS Uniphase in 2004. He is an inventor of more than 90 US patents and an author of 4 book chapters and more than 50 peer reviewed technical papers.
Follow Wenbin Jiang:
About Cytek Biosciences: Cytek Biosciences is a manufacturer and supplier of flow cytometry products and services.
Colleen Cutcliffe
Co-Founder and CEO of Pendulum Therapeutics
Colleen Cutcliffe is the Co-Founder and CEO of Pendulum Therapeutics.
Follow Colleen Cutcliffe:
About American Diabetes Association, California Life Sciences Association, Pendulum Therapeutics: Pendulum Therapeutics is a biotechnology company improving health through products targeting the microbiome.
Amit Munjal
Founder & CEO of Doctor Insta
Amit is the Founder and Chief Executive Officer of Doctor Insta. In his previous role, He was a CFO and Head of Investment Strategy at the $120 Billion Division of CitiGroup. Amit has multiple years of experience in Management Consulting, Private Equity, and Venture Capital and is a Subject Matter Expert in Scaling/Growth and Profit Optimization at e-commerce startups and Fortune 500 companies. Amit has been an active mentor and advisor to many startups in the USA and India and has been involved with Capital Innovators, St Louis, MO (USA)- one of the top 10 accelerators of the Country. Prior to his last role, Amit was a Senior Vice President of Growth & Investment Strategy at Bank of America and also did stints in Corporate Strategy Practice of Deloitte Consulting, in Corporate Development (M&A) with Randstad, and in Venture Capital with Kauffman Foundation. Amit has an MBA from Indiana University-Bloomington (where he was actively involved with Johnson Center of Entrepreneurship and Innovation), Advanced Management Certification from Harvard Business School, and is a CFA Charterholder from CFA Institute, USA. In his spare time, he likes to travel, work out, read and try out new restaurants.
Follow Amit Munjal:
About Doctor Insta: Bringing Healthcare to Everyone’s fingertaps; India’s 1st Video Medicine Company where One can consult Care-Givers anytime, anywhere.
Julia Hu
CEO of Lark
Having been too often sleep deprived and dropping off exercise and diet regimens, Julia’s goal is to make people happier and healthier as the CEO of lark technologies. Named Top 10 Most Innovative CE Companies in the World by Fast Company, lark is a mobile and wireless technology company that uses behavior change to personally coach people to feel great. A serial entrepreneur, she has focused on growing early-stage startups in the consumer products and cleantech space. Prior to lark, she ran global startup incubator Clean Tech Open, her own green buildings startup, and worked in China to build consumer electronics with D.light Design. She received her master’s and bachelor’s degrees at Stanford University and half a MBA from the MIT Sloan (a dropout, but they were kind enough to make lark a casestudy). She was an entrepreneur in residence at Stanford’s StartX incubator, and named Top Woman Entrepreneur Under 40 by Marie Claire Magazine.
Follow Julia Hu:
About Lark: Lark is a digital health startup that provides virtual care through AI coaching, smart devices, and tele-monitoring.
Florian Bohn
CEO & Co-Founder of GuRu
Florian has always felt compelled to understand the way the world works. His curiosity moved him to study Electrical Engineering at Caltech (B.S. Cum Laude), to receive an M.S. in Electrical and Computer Engineering from UC Santa Barbara, and a Ph.D. in Electrical Engineering from Caltech. At GuRu, Florian is thrilled to be building technology that will enrich people’s lives on a global scale. He is also proud to be building a community of passionate and like-minded engineers at the organization. As a co-founder and CEO at GuRu, Florian brings years of technology experience. At Axiom Microdevices, he helped define and implement high-frequency RF integrated circuits which have shipped more than 400 million units. At Agilent Laboratories (formerly HP Labs) he worked on clock and data recovery circuits as well as novel test and measurement systems. As a Caltech Lead Scientific Researcher, Florian guided engineering and operational aspects of implementing the microwave system at Caltech’s Space Solar Power Initiative.
Follow Florian Bohn:
About GuRu: Enables safe, effective and customizable transmission of power over-the-air using proprietary mmWave and Smart RF Lensing technology
Andrew Hines
CEO of Canvas Medical
Andrew founded Canvas Medical in 2015 and leads the team. Prior to Canvas, Andrew built one of the largest real-time analytics tools in healthcare at Practice Fusion and led large-scale data science teams in the advertising and travel industries. He holds an MS from the Stanford School of Engineering. His wife, Anna, is a family nurse practitioner at a safety net clinic in San Francisco; her experience with electronic health records inspired him to start Canvas. Andrew enjoys spending time with his wife and son, surfing, and trail running on mountainous terrain.
Follow Andrew Hines:
About Canvas Medical: Canvas Medical is a healthcare platform for primary care practices.
Nancy Yu
Co-Founder & CEO of AllStripes
Nancy previously led Corporate Development at 23andMe, the largest consumer genetics company. She worked on 23andMe’s next generation sequencing platform, drug discovery strategy, and business development programs. Before that, she worked on Wall Street as a biopharma investment banker. Nancy began her career doing genetics research at the University of Pennsylvania. She’s passionate about bridging the gap between patients and industry to make drug R&D cheaper, faster, and better.
Follow Nancy Yu:
About AllStripes: AllStripes is a healthcare technology company that accelerates drug development and research for the treatment of rare diseases.
Gary Guthart
CEO of Intuitive Surgical
Gary Guthart joined Intuitive Surgical in April 1996. Effective January 2010, Guthart was appointed as Chief Executive Officer. In July 2007, he was promoted to President. Prior to that, in February 2006, Guthart assumed the role of Chief Operating Officer. Prior to joining Intuitive, Guthart was part of the core team developing foundation technology for computer enhanced-surgery at SRI International (formerly Stanford Research Institute). Guthart is currently a member of the Board of Directors of Affymetrix, Inc. He received a B.S. in Engineering from the University of California, Berkeley and an M.S. and a Ph.D. in Engineering Science from the California Institute of Technology.
Follow Gary Guthart:
About Intuitive Surgical: The da Vinci Surgical System is changing the experience of surgery for patients around the world.
Ayub Khattak
Founder & CEO of Cue
Ayub Khattak is the CEO and founder at Cue.
Follow Ayub Khattak:
About Cue: Cue helps users track their health at the molecular level, revealing the interplay of activity, food, and sleep.
Arad Rostampour
CEO and Founder of Zenamins
Arad Rostampour is Founder at Zenamins.
Follow Arad Rostampour:
About Zenamins: Zenamins is a subscription service that home delivers a monthly box of preferred vitamins to its subscribers.
Richard Lin
CEO & Co Founder of Ombre
Follow Richard Lin:
About Ombre: Ombre is a provider of a microbiome testing kit designed to incorporate personalized probiotics and microbiome testing.
Gerrit Klaerner
Chief Executive Officer & President of Tricida
Gerrit joined Relypsa in October 2007 after negotiating the Relypsa spin out transaction from Amgen as an advisor to the lead investor 5AM Ventures. He co-founded Ilypsa in 2003 while at Symyx Technologies. Between 2003 and 2007, Gerrit held varying positions at Ilypsa and was in charge of the series A and B financings on the company side and licensing deals with Astellas and Cubist. As Ilypsa’s Chief Business Officer, Gerrit co-led the M&A negotiations and diligence efforts. Prior to Ilypsa, he joined Symyx in 1998 as a Staff Scientist, and was later promoted to Director of Business Development. Gerrit received his Ph.D. in polymer chemistry from the Max-Planck-Institute for Polymer Research in Mainz, Germany. He conducted postdoctoral research at Stanford University and the IBM Almaden Research Center.
Follow Gerrit Klaerner:
About Tricida: Tricida operates in the healthcare industry focusing on pharmaceutical business.
Sourav Sinha
Co-founder, CEO of Oncolinx
Sourav Sinha is the Founder and CEO of Oncolinx LLC. Oncolinx is an early-stage bio-oncology company focused on creating targeted cancer therapies carry drugs directly to cancer cells and not healthy cells–avoiding many of the adverse side-effects of cancer. Oncolinx is partnered with more than 15 leading pharmaceutical partners, and 6 academic labs all over the world. Sourav also serves as the Entrepreneur In Residence of The Center For Advancing Innovation (CAI), a first-of-its-kind initiative to spin out the best inventions from the NIH, NCI, NASA, and other government funded agencies. Most uniquely, the fund redirects much of the value created into regional endowments to create jobs, increase prosperity, and support future sustainability. Sourav was named as a top 50 global entrepreneur under the age of 25 by Inc. Magazine and has been published in top scientific journals. Sourav holds an AB from Dartmouth College in Molecular Biology and Biochemistry, an MA in Biomedical Sciences from Rutgers Biomedical Health Sciences, and is a graduate of the Singularity University Global Solutions Program.
Follow Sourav Sinha:
About Longevity Vision Fund, Oncolinx, The World Economic Forum: Oncolinx is developing antibody-drug conjugates.
Fred Moll, M.D
CEO of Hansen Medical
Frederic H. Moll, M.D. serves as Chief Development Officer of Johnson & Johnson’s Digital Surgery Group. Prior to Johnson & Johnson, Dr. Moll was CEO of Auris Health, Inc., located in Redwood City, California. Prior to Auris, Dr. Moll founded Hansen Medical and served as the company’s first CEO, and in 1995, founded Intuitive Surgical, Inc. (Nasdaq: ISRG). Dr. Moll earned a M.D. from the University of Washington, School of Medicine, a M.S. degree in Management from Stanford University’s Sloan Program, and a B.A. degree from the University of California at Berkeley.
Follow Fred Moll, M.D:
About Hansen Medical, Hansen Medical, Intuitive Surgical, Johnson & Johnson, Sonder Capital: Hansen Medical designs and manufactures medical robotics for the accurate positioning and control of catheter-based technologies.
Sy Fahimi
Co-Founder and CEO of DocSpera
Sy Fahimi serves as a Member of the Executive Team and Operating Partner at Symphony Technology Group. He was Executive-in-Residence at the firm. Fahimi leads the strategy and innovation charter across several portfolio companies. Until 2012, Fahimi was In Charge of Yahoo’s Monetization and Emerging Market products. Prior to 2012, he held various Vice President positions including Head of Yahoo’s Advertising Products globally, which also encompassed mobile, video, and social monetization. He ran Yahoo Small Business and Emerging Markets Products for the company. He served as the Chief Executive Officer of Adteractive, Inc. He joined Adteractive in October 2005. He served as the Managing Director of West Coast Office of SSA & Company, LLC since January 26, 2009. Fahimi has diverse experience with privately held, venture-backed and large public technology companies, along with SSA & Company’s long-standing consulting credibility and process improvement thought leadership. Prior to joining Adteractive, Fahimi spent most of his career in senior executive positions at Fortune 500 companies including Intuit, Sun Microsystems, and General Electric, where he held several executive positions including Operations, Marketing, Sales Ops, Risk Management, Quality, Finance, and Org./Process Excellence. During his tenure at GE, he became a certified Master Black Belt in the Six Sigma methodology, and served in two Vice President Positions. Fahimi began his career at GE, where he provided audit and consulting services to a wide variety of business units around the globe. In 2000, he joined Sun Microsystems as a Director of Six Sigma Quality and Customer Advocacy. After becoming a Senior Director of Global Sales Operations at Sun, he joined Intuit Corporation in a number of operating, customer advocacy, and process/organizational leadership roles. As an active entrepreneur over the last ten years, he has served as an Advisor, Investor or Board Member to several technology enabled start-ups such as Mint (Intuit), Empire Avenue, Sales Portal, Progresso Financiero, Blackfire Research Corporation, as well as being the Co-Founder of Compliant Innovations. Fahimi served as an Advisor, providing consulting services and early stage investment guidance to select start-up companies in Silicon Valley. He has been a Director of Empire Avenue Inc. since December 10, 2013. He has experience in international software, e-commerce, and digital media. Fahimi earned an M.B.A. from the Anderson School of Business at UCLA and a Bachelors degrees from University of California at Berkeley in and EconomicsEngineering .
Follow Sy Fahimi:
About DocSpera, Symphony Technology Group: DocSpera provides web and mobile solutions addressing surgical care coordination challenges facing health systems & devices
Phil Martie
Co-Founder, CEO of Nicolette
Follow Phil Martie:
About Nicolette: Nicolette operates as a patient empowerment company.
Gibb Clarke
CEO and Co-Founder of Blockade Medical
Gibb Clarke is co-founder and CEO of Blockade Medical and has more than 10 years experience as a medical device executive with a specific focus on new technology development for the interventional neurovascular marketplace. Prior to co-founding Blockade, Gibb co-founded Pulsar Vascular, Inc. in 2006. A novel therapeutic approach for challenging and complex cerebral aneurysms. Gibb successfully raised multiple rounds of venture capital as well as helped craft and manage the clinical and regulatory strategy for both CE Mark and US approvals. Prior to Pulsar, Gibb played a critical early role in helping Swedish Medical Center in Seattle, WA, plan for and execute the development of The Seattle Neuroscience Institute, a neuroscience center for excellence. Gibb’s efforts resulted in Swedish Medical investing in excess of $35M into the development of its now flagship neuroscience center located in Seattle, WA. Gibb also spent 8 years in the US Marines Corps serving as a team leader in the elite Marine Recon unit. Military schoolings include Amphibious Recon Course, Army Ranger School, US Navy Dive School, and Army Jump School. Gibb is an avid endurance athlete, having competed in over 200 races.
Follow Gibb Clarke:
About Blockade Medical: Founded in 2011, Blockade Medical is a privately held company dedicated the development of catheter based therapeutic devices for the
Zak Holdsworth
Co-Founder & CEO of Hint Health
Zak Holdsworth is the Co-founder & CEO at Hint Health.
Follow Zak Holdsworth:
About Hint Health: Hint Health fixes healthcare system by fundamentally restructuring the way that care is delivered.
Jeffrey Brewer
President & CEO of Bigfoot Biomedical
Follow Jeffrey Brewer:
About Bigfoot Biomedical: Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.
Thomas W. Burns
President & Chief Executive Officer of Glaukos
Thomas W. Burns has served as our president, chief executive officer and as a member of our board of directors since March 2002. Mr. Burns has also been a member of the board of directors of DOSE Medical Corporation since October 2009 and its chief executive officer and president since March 2010. Mr. Burns has a proven record of building successful medical device and pharmaceutical businesses and creating successful new markets in ophthalmology. Mr. Burns has more than 25 years of direct ophthalmic management experience, including over 20 years of general management experience across a broad range of ophthalmic medical devices, ophthalmic pharmaceuticals, drug delivery technologies, surgical products and over-the counter products. Prior to joining our company, Mr. Burns led Eyetech Pharmaceuticals, Inc. (acquired by OSI Pharmaceuticals, Inc.) as its president and chief operating officer, and a director. From 1990 to 1997, Mr. Burns served as senior vice president and general manager of Chiron Vision Corporation (acquired by Bausch & Lomb, Inc.), and then as vice president, global strategy and general manager, refractive surgery of Bausch & Lomb from 1998 to 2000. Mr. Burns has also served as an entrepreneur-in residence at Versant Ventures Management, LLC, an entity affiliated with one of our principal stockholders. Mr. Burns received a B.A. from Yale University. We believe Mr. Burns’ extensive understanding of our business, operations and strategy, as well as significant industry experience and corporate management skills and experience qualify him to serve onour board of directors.
Follow Thomas W. Burns:
About Glaukos: Glaukos is a glaucoma treatment company developing micro-bypass therapies to moderate the intraocular pressures that help preserve vision.
Nima Farzan
Chief Executive Officer of Kinnate Biopharma
Nima Farzan is the chief executive officer of Kinnate Biopharma. He has his MBA from Harvard Business School and an undergraduate degree in Human Biology from Stanford University.
Follow Nima Farzan:
About Kinnate Biopharma: Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.
Don Listwin
CEO of RapidAI
Don Listwin is the CEO of RapidAI. Don Listwin is also a distinguished networking industry veteran with more than 20 years of experience, including a decade at Cisco Systems, and served as president and CEO of Openwave Systems Inc., the world’s leading provider of open software and services for the communications industry. Listwin helped launch NetAid, an innovative nonprofit organization that partners with the United Nations to provide corporations, groups and individuals concrete ways to fight extreme poverty in developing countries. Listwin is the founder of the Canary Foundation and a member of the Board of Trustees at the Fred Hutchinson Cancer Research Center in Seattle Washington.
Follow Don Listwin:
About Canary Foundation, RapidAI: RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke and aneurysm patients.
Billoo Rataul
President & CEO of Paramit Corporation
Billoo Rataul is the President & CEO at Paramit Corporation.
Follow Billoo Rataul:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Kelsey Mellard
CEO & Co-Founder of Sitka
Kelsey Mellard is the CEO and Founder of Sitka, a first-of-its-kind medical vConsults platform and specialty provider network. She launched Sitka in 2018 to help improve access to and delivery of specialty care across the nation. Prior to founding Sitka, Kelsey led Health System Integration at Honor, a comprehensive technology-backed home care company. Before joining the Honor, Kelsey led the development of the Post-Acute Care Center for Research (PACCR), which she served as its Executive Director. Kelsey also served in VP roles at naviHealth, UnitedHealth Group, the Center for Medicare and Medicaid Innovation (CMMI), and held positions at Advisory Board Company, Children’s Mercy Hospitals and Clinics, and Kaiser Family Foundation. Kelsey holds a Bachelor’s of Science Degree in Community Health from Winona State University and a Master’s degree in Public Administration from the University of Kansas. She also currently serves as an adjunct faculty member at Winona State University in the College of Nursing and Health Services.
Follow Kelsey Mellard:
About Sitka, Winona State University: Sitka is a customizable video software platform that connects primary care providers to the virtual specialty provider network.
Mark Mastalir
Co-CEO & Chief Marketing Officer of Halo Neuroscience
Follow Mark Mastalir:
About Halo Neuroscience: Halo Neuroscience is a neurotech company focused on using electrical neurostimulation to unlock human performance and treat human disease
Maryam Ziaei
Co-Founder & Chief Executive Officer of iSono Health
Maryam Ziaei is the Co-Founder & CEO at iSono Health.
Follow Maryam Ziaei:
About iSono Health: iSono Health develops an AI platform for accessible and personalized breast health monitoring
Tyler Shultz
Co-Founder & CEO of Flux Bioscience
Tyler Shultz is an entrepreneur fostering innovation in healthcare.
Follow Tyler Shultz:
About Ethics in Entrepreneurship, Flux Bioscience: Flux Biosciences is a company spun out of Stanford University, where the technology used to read and write computer hard drives .
